During the past decade, Georgia Retina conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Georgia Retina" #1 collaborator was "Stada Arzneimittel AG" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Georgia Retina" are "Geographic Atrophy" (1 trials), "Macular Degeneration" (1 trials), "Neovascular Age-related Macular Degeneration" (1 trials) and "Nonproliferative Diabetic Retinopathy" (1 trials). Many other conditions were trialed in "Georgia Retina" in a lesser frequency.

Most popular intervention types in "Georgia Retina" are "Drug" (2 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "AKB-9778" (1 trials), "APL-2" (1 trials), "Placebo" (1 trials), "Ranibizumab" (1 trials) and "Sham Procedure" (1 trials). Other intervention names were less common.

The vast majority of trials in "Georgia Retina" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Georgia Retina". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Georgia Retina, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Georgia Retina, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".